Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer that does not express estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) on the cell surface [1,2]. This evidence concerns the gene ERBB2 and breast carcinoma.